Progenics pharmaceuticals inc (PGNX)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenues:
Revenue

36,953

34,986

23,098

22,802

16,714

15,622

16,273

13,653

12,540

11,698

6,436

57,589

63,300

69,429

75,897

23,443

16,904

8,676

3,010

43,270

42,810

44,377

47,916

7,127

7,451

7,862

13,779

14,029

14,048

14,048

10,967

84,257

0

-

0

0

-

-

-

Research grants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

275

346

589

600

488

881

2,319

3,632

4,810

5,580

4,688

0

0

0

Other revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

134

131

127

113

37

39

58

80

90

86

82

69

83

90

75

72

132

150

150

176

119

146

0

0

0

Operating expenses:
Cost of goods sold

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

47,198

49,223

46,511

43,162

39,429

35,147

36,495

38,749

40,694

42,589

43,407

42,890

39,586

37,569

33,744

30,965

29,695

28,196

27,352

27,032

28,162

28,592

29,866

31,043

32,780

34,582

31,126

30,772

29,144

31,332

34,713

39,568

44,913

53,183

57,854

56,107

0

0

0

Selling, general and administrative

49,123

47,838

43,357

38,959

31,958

29,431

28,264

27,147

25,911

24,909

22,924

24,186

23,452

23,356

22,178

19,530

20,058

18,184

18,757

18,080

15,809

15,489

15,353

14,589

14,632

15,541

14,805

15,681

15,807

15,214

15,788

15,845

16,772

18,248

19,627

21,243

0

0

0

Intangible impairment charge

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License fees - research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

824

1,243

1,200

1,170

672

276

254

578

676

853

0

0

0

Total revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Royalty expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

387

387

430

499

551

625

533

405

336

247

0

0

0

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

1,035

1,147

1,129

1,324

1,548

1,777

2,002

2,066

2,113

2,467

0

0

0

Intangible impairment charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Change in contingent consideration liability

-284

916

1,416

-6,084

-5,700

-5,800

-6,600

2,100

1,500

2,600

-3,100

-3,200

-3,300

-4,600

2,500

1,700

1,900

1,600

1,000

1,700

1,300

1,500

1,400

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

100,763

101,145

93,094

99,730

88,887

81,978

81,359

67,996

68,105

70,098

63,231

63,876

59,738

56,325

58,422

52,195

51,653

47,980

47,962

48,712

47,631

48,257

47,765

46,974

48,484

50,842

48,177

49,230

47,710

49,539

53,272

58,091

64,474

74,480

80,606

80,917

0

0

0

Other operating income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Operating loss

-63,810

-66,159

-69,996

-76,928

-72,173

-66,356

-65,086

-54,343

-55,565

-58,400

-56,795

-6,287

3,562

13,104

17,475

-28,752

-34,749

-39,304

-44,952

1,808

2,429

3,370

7,401

-39,847

-41,033

-42,980

-34,398

-35,201

-33,662

-35,491

-45,912

-46,044

20,160

10,316

3,960

150

0

0

0

Other (expense) income:
Interest (expense) income and other income, net

-2,791

-2,376

-2,068

-2,104

-2,427

-2,933

-3,753

-4,038

-4,184

-4,285

-3,933

-2,807

-1,688

-527

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

0

0

-

47

47

44

46

53

55

59

60

59

60

62

65

66

67

0

0

0

Total other (expense) income

-2,791

-2,376

-2,068

-2,104

-2,427

-2,933

-3,753

-4,038

-4,184

-4,285

-3,944

-2,818

-1,688

-527

206

137

94

52

47

49

51

51

47

47

44

46

53

55

59

60

59

60

62

65

66

67

0

0

0

Loss before income tax (expense) benefit

-

-

0

0

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

Income tax (expense) benefit

-

-

-

-

-

-

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

Net (loss) income

-

-

-

-

-

-

-

-

-

-

-

-

-

10,733

17,814

-28,482

-34,522

-39,119

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss attributable to noncontrolling interests

-

-

-

-

-

-

-

-

-

-

-

-

-

-73

-66

-45

-26

-7

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-66,618

-68,552

-71,981

-77,496

-72,968

-67,657

-55,618

-46,613

-48,077

-51,013

-62,569

-10,914

84

10,806

17,880

-28,437

-34,496

-39,112

-44,144

2,845

3,469

4,410

8,038

-39,437

-40,627

-42,572

-34,345

-35,146

-33,603

-35,431

-45,853

-45,984

20,222

10,381

4,026

217

0

0

0

Net (loss) income per share attributable to Progenics - basic (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.52

-

-

-

-0.14

-

-

-0.16

0.53

-0.16

-0.15

-0.13

-0.17

-0.24

-0.22

0.02

-0.33

-0.32

-0.39

-

-0.34

1.66

-

-0.52

-0.47

Weighted-average shares - basic (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

69,705

-

-

69,665

69,556

69,561

63,958

60,996

60,599

51,481

50,116

37,609

33,848

33,798

33,761

-

33,710

33,510

-

-

-

Net (loss) income per share attributable to Progenics - diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.52

-

-

-

-0.14

-

-

-

0.51

-

-

-

-0.17

-

-

-

-

-

-

-

-0.34

1.64

-

-

-

Weighted-average shares - diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

70,297

-

-

-

69,705

-

-

-

72,879

-

-

-

60,599

-

-

-

-

-

-

-

33,710

33,787

-

32,814

32,396

Net loss per share - basic and diluted (in dollars per share)

-0.19

-0.13

-0.22

-0.23

-0.22

-0.18

-0.30

-0.20

-0.19

-0.04

-0.22

-0.24

-0.23

-

-

-0.08

-0.08

-

-

-0.17

-0.15

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.69

-0.52

-0.47

Weighted-average shares - basic and diluted (in shares)

86,582

86,465

86,421

85,000

84,542

84,701

80,325

74,017

72,517

70,468

70,270

70,202

70,196

-

70,013

69,947

69,947

-

-

69,647

69,637

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

33,273

32,814

32,396

Product [Member]
Revenue

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Royalty [Member]
Revenue

17,598

16,970

15,817

16,074

16,011

14,908

14,319

0

0

-

0

-

-

10,295

11,532

9,421

8,814

6,608

2,528

2,946

2,540

3,101

6,599

5,692

5,501

5,923

3,834

3,843

4,286

4,963

5,460

5,972

4,880

3,046

2,387

1,728

0

0

0

License and Other [Member]
Revenue

16,437

16,457

6,502

6,719

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product and Service, Other [Member]
Revenue

-

-

-

-

-

-

-

-

0

-

0

-

-

59,134

64,231

13,891

7,963

1,955

445

40,285

40,212

41,196

41,227

1,349

1,791

1,595

9,516

9,507

9,087

8,525

887

3,606

75,972

76,764

76,480

74,505

0

0

0